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Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are 
not associated with the incidence of patent ductus arteriosus in 
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Persistent patent ductus arteriosus (PDA) is a frequent complication in preterm infants. 
Single nucleotide polymorphisms (SNP) in several genes, including angiotensin II 
receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B) and tumor necrosis 
factor receptor-associated factor 1 (TRAF1), have been reported to be associated with 
PDA in preterm infants. The aim of this study was to evaluate the relationships between 
PDA in preterm infants and polymorphisms in AGTR1, TFAP2B and TRAF1 in the 
Japanese population. The subjects consisted of 107 preterm infants with gestational age 
<32weeks. Extremely low-birthweight infants were treated with prophylactic 
indomethacin during the first 24 h after birth. Five SNP, namely, rs5186 in AGTR1, 
rs987237 and rs6930924 in TFAP2B, and rs1056567 and rs10985070 in TRAF1, were 
genotyped using TaqMan SNP genotyping assays. There were no significant differences 
in the distributions of the genotypes and allele frequencies of all studied SNP between 
the PDA group (n = 46) and the non-PDA group (n= 61). There were no significant 
associations between the studied SNP and the incidence of PDA in Japanese preterm 
infants. These SNP may not be clinically important predisposing factors for PDA in 
Japanese preterm infants. 
